Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Immunological control of congenital toxoplasmosis in the murine model

Menzies, Fiona M. and Henriquez, Fiona L. and Roberts, Craig W. (2008) Immunological control of congenital toxoplasmosis in the murine model. Immunology Letters, 115 (2). pp. 83-89. ISSN 0165-2478

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

Toxoplasmosis is a serious disease in humans where it can cause abortion or congenital infection if a women is exposed to disease for the first time during pregnancy. Infection prior to pregnancy normally results in immunity and which is capable of protecting the foetus. Similar observations have been made in the BALB/c mouse indicating the potential of mice for studying congenital disease. Consequently, the mouse has been used to study how mammals balance the opposing needs of maintaining an immunological environment conducive to successful pregnancy while attempting to control a dangerous pathogen. Moreover the mouse has proven useful for testing the potential of a number of vaccine candidates and adjuvants for their ability to prevent congenital infection and/or reduce foetal death and abortion.